切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2022, Vol. 10 ›› Issue (03) : 306 -311. doi: 10.3877/cma.j.issn.2095-5782.2022.03.015

综述

梗阻性黄疸经皮肝穿刺胆道引流术后并发感染的多因素分析
娄琳滟1, 王黎洲1,(), 周石1, 蒋天鹏1, 雷东酿1, 郑星1   
  1. 1. 550004 贵州贵阳,贵州医科大学附属医院介入科
  • 收稿日期:2021-08-03 出版日期:2022-08-25
  • 通信作者: 王黎洲
  • 基金资助:
    贵州省普通高等学校医学影像工程研究中心建设项目(黔教合KY字2016-012); 贵州医科大学医学影像工程研究中心建设项目(2016001)

Obstructive jaundice after PTCD with infection: analysis of multiple factors

Linyan Lou1, Lizhou Wang1,(), Shi Zhou1, Tianpeng Jiang1, Dongniang Lei1, Xing Zheng1   

  1. 1. Department of Intervention Therapy, the Affiliated Hospital of Guizhou Medical University, Guizhou Guiyang 550004, China
  • Received:2021-08-03 Published:2022-08-25
  • Corresponding author: Lizhou Wang
引用本文:

娄琳滟, 王黎洲, 周石, 蒋天鹏, 雷东酿, 郑星. 梗阻性黄疸经皮肝穿刺胆道引流术后并发感染的多因素分析[J/OL]. 中华介入放射学电子杂志, 2022, 10(03): 306-311.

Linyan Lou, Lizhou Wang, Shi Zhou, Tianpeng Jiang, Dongniang Lei, Xing Zheng. Obstructive jaundice after PTCD with infection: analysis of multiple factors[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(03): 306-311.

梗阻性黄疸是临床常见肝胆疾病,有相关症状的患者若未得到及时有效的治疗,大量淤积的胆汁除表现出皮肤巩膜黄染外,可快速地引起肝肾功能衰竭、凝血功能障碍甚至威胁患者生命。经皮肝穿刺胆道引流(PTCD)是临床常用解除胆道梗阻并引流胆汁的有效手段,但感染是PTCD术后常见并发症,可能会对患者的预后产生影响,严重情况下可造成患者围手术期死亡。文章就PTCD术后感染的影响因素进行综述,以期更好地防治术后感染,提高患者的生存率。

Obstructive jaundice is a common clinical hepatobiliary disease. If patients with related symptoms are not treated promptly and effectively, the massive accumulation of bile can rapidly cause liver and kidney failure, coagulation dysfunction, and even threaten patients' lives, in addition to manifesting yellow sclerae of the skin. Percutaneous transhepatic cholangial drainage (PTCD) is an effective means of relieving biliary obstruction and draining bile, but infection is a common complication after PTCD, which may affect the patient's prognosis and may cause perioperative death in severe cases. In this paper, we review the factors influencing postoperative infection in PTCD in pursuit of a better prevention and control of postoperative infection and improve the survival rate of patients.

[1]
Dorcaratto D, Hogan NM, Muñoz E, et al. Is percutaneous transhepatic biliary drainage better than endoscopic drainage in the management of jaundiced patients awaiting pancreaticoduo-denectomy? A systematic review and meta-analysis[J]. J Vasc Interv Radiol, 2018, 29(5): 676-687.
[2]
Cao JQ, Wang ZX, Cai HZ, et al. Effect of PTCD-based biliary stent placement combined with 125I particle intracavitary irradiation in treating pancreatic head cancer[J]. J BUON, 2020, 25(2): 1056-1062.
[3]
Zhu JH, Wu W, Hu KW, et al. Percutaneous transhepatic cholangiography and drainage and endoscopic retrograde cholangiopancreatograph for hilar cholangiocarcinoma: which one is preferred?[J]. Rev Esp Enferm Dig, 2020, 112(12): 893-897.
[4]
Tang K, Sui LL, Xu G, et al. Effects of different palliative jaundice reducing methods on immunologic functions in patients with advanced malignant obstructive jaundice[J]. Anticancer Res, 2017, 37(8): 4665-4670.
[5]
Wu J, Song L, Zhang Y, et al. Efficacy of percutaneous transhepatic cholangiodrainage (PTCD) in patients with unresectable pancreatic cancer[J]. Tumor Biology, 2014, 35(3): 2753-2757.
[6]
谢兴武, 唐先志, 吴鹏, 等. 经皮肝穿刺胆道引流术后胆道感染的主要病原菌类型及药敏试验分析[J]. 中华介入放射学电子杂志, 2018, 6(4): 306-310.
[7]
咸蕾, 薛苏阳, 庄树武, 等. 胆道支架联合经皮肝穿刺胆管引流术治疗恶性梗阻性黄疸的临床疗效[J]. 中国老年学杂志, 2016, 36(17): 4250-4251.
[8]
Pedersoli F, Schröder A, Zimmermann M, et al. Percutaneous transhepatic biliary drainage (PTBD) in patients with dilated vs. nondilated bile ducts: technical considerations and complications[J]. European radiology, 2021, 31(5): 3035-3041.
[9]
Ahn S, Lee YS, Lim KS, et al. Malignant biliary obstructions: can we predict immediate postprocedural cholangitis after percutaneous biliary drainage?[J]. Support Care Cancer, 2013, 21(8): 2321-2326.
[10]
李阳, 张庆桥, 茅一萍, 等. 介入操作对不同疾病患者术后感染及相关因素分析[J]. 中华医院感染学杂志, 2018, 28(8): 1224-1228.
[11]
Ginat D, Saad WE, Davies MG, et al. Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients[J]. AJR, 2011, 196(1): W73-W77.
[12]
成丕光, 王建强, 石天亭, 等. 梗阻性黄疸患者经皮肝穿胆道引流术后胆道感染的分析[J]. 中华医院感染学杂志, 2016, 26(12): 2753-2755.
[13]
王炜, 刘会春, 庞青, 等. 经皮胆道双金属支架植入治疗恶性高位胆道梗阻的疗效[J]. 介入放射学杂志, 2019, 28(8):773-777.
[14]
Federico P, Anja S, Markus Z, et al. Percutaneous transhepatic biliary drainage (PTBD) in patients with dilated vs. nondilated bile ducts: technical considerations and complications[J]. European Radiology, 2021, 31: 3035-3041.
[15]
程龙, 靳勇, 白旭明, 等. 经皮经肝胆道引流术后胆道感染的相关因素分析[J]. 介入放射学杂志, 2012, 21(6): 509-513.
[16]
陈伟伟, 黄坤, 刘锐, 等. 经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析[J]. 临床肝胆病杂志, 2019, 35(3): 559-564.
[17]
黄凯鹏, 李哲, 赵龙栓. 两种不同经皮肝穿刺胆道引流术的疗效观察[J]. 中华普通外科杂志, 2018, 33(5): 385-387
[18]
孙瑞杰, 林华鹏. 急性梗阻性化脓性胆管炎PTCD术后感染的病原菌分布及相关因素分析[J]. 中国病原生物学杂志, 2020. 15(7): 842-845.
[19]
贾一平, 茅爱武, 蒋霆辉, 等. 梗阻性黄疸经皮肝穿刺胆道引流感染发生因素的探讨[J]. 东南大学学报(医学版), 2015, 34(3): 352-356.
[20]
Xu C, Huang XE, Wang SX, et al. Comparison of infection between internal-external and external percutaneous transhepatic biliary drainage in treating patients with malignant obstructive jaundice[J]. Asian Pac J Cancer Prev, 2015, 16(6): 2543-2549.
[21]
刘锐, 黄坤, 陈伟伟, 等. 胆道支架治疗恶性梗阻性黄疸早期疗效及其影响因素[J]. 中国介入影像与治疗学, 2019, 16(5): 264-269.
[22]
de Jong EA, Moelker A, Leertouwer T, et al. Percutaneous transhepatic biliary drainage in patients with postsurgical bile leakage and nondilated intrahepatic bile ducts[J]. Dig Surg, 2013, 30(4-6): 444-450.
[23]
夏卿, 周新锋, 范晓翔, 等. 梗阻性黄疸患者经皮经肝胆道引流术后胆道感染相关因素研究[J]. 中华医院感染学杂志, 2017, 27(17): 3960-3963.
[24]
刘凌云, 鲁杰, 李香瑞. 经皮经肝胆道引流术后胆道感染的相关因素分析[J]. 中华医院感染学杂志, 2014, 24(24): 6165-6167.
[25]
Nennstiel S, Weber A, Frick Günter, et al. Drainage-related complications in percutaneous transhepatic biliary drainage: an analysis over 10 years[J]. J Clin Gastroenterol, 2015, 49(9): 764-770.
[26]
康庆民, 侯文静, 刘金龙, 等. 经皮穿肝胆管支架置入术治疗恶性梗阻黄疸发生早期胆道感染的风险及对策[J]. 中国现代医学杂志, 2016, 26(10): 84-88.
[27]
胡琦嵘, 王林俊, 丁孟德, 等. 梗阻性黄疸患者引流术后胆道感染的临床相关因素分析[J]. 中华医院感染学杂志, 2016, 26(10): 2296-2298.
[28]
黄继续, 陈蓉蓉, 翁溢鑫, 等. 介入治疗梗阻性黄疸患者胆道感染的影响因素分析[J]. 中华医院感染学杂志, 2019, 29(3): 415-417, 421.
[29]
朱飚, 傅建, 朱翔宇, 等. 恶性梗阻性黄疸患者PTCD术后胆道感染病原学与影响因素[J]. 中华医院感染学杂志, 2020, 30(23): 3644-3648.
[30]
Delden OMV, Laméris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction[J]. European Radiology, 2008, 18(3): 448-456.
[31]
Yu HP, Sun YY, Guo Z, et al. Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction[J]. J Cancer Res Ther, 2018, 14(7): 1503-1508.
[32]
范小斌, 徐明洲, 贾亚鹏, 等. 恶性梗阻性黄疸PTCD术后胆道感染危险因素及sCD14-ST诊断价值[J]. 中华医院感染学杂志, 2021, 31(2): 233-237.
[33]
周欣, 姚高琼, 朱深银. 干预前后血管介入手术预防性应用抗菌药物的调查分析[J]. 重庆医学, 2015, 44(3): 369-371.
[34]
田甜, 李健健, 李艳, 等. 妇产科Ⅱ类切口围手术期预防应用抗生素的研究[J]. 中国妇产科临床杂志, 2017, 18(3): 261-262.
[35]
徐安辉, 漆剑频, 王南. 经皮腔内下肢血管成形术前预防性应用抗生素必要性研究[J]. 介入放射学杂志, 2015, 24(4): 297-300.
[36]
Turan AS, Jenniskens S, Martens JM, et al. Complications of percutaneous transhepatic cholangiography and biliary drainage, a multicenter observational study[J]. Abdom Radiol (NY), 2021. doi: 10.1007/s00261-021-03207-4.
[37]
黄光明. 介入治疗中抗生素的应用进展[J]. 中国介入影像与治疗学, 2016, 13(2): 122-125.
[38]
Heedman PA, Åstradsson E, Blomquist K, et al. Palliation of malignant biliary obstruction: adverse events are common after percutaneous transhepatic biliary drainage[J]. Scand J Surg, 2018, 107(1): 48-53.
[39]
Venkatanarasimha N, Damodharan K, Gogna A, et al. Diagnosis and management of complications from percutaneous biliary tract interventions[J]. Radiographics, 2017, 37(2): 665-680.
[40]
陈立军, 彭靖, 马军亮, 等. 急性结石性胆囊炎腹腔镜胆囊切除术预防性应用抗生素的疗效观察[J]. 中国普通外科杂志, 2019, 28(8): 1018-1022.
[41]
郭冬杰, 史录文, 张相林. 我院围术期预防使用抗菌药物改进情况分析[J]. 中国药学杂志, 2013, 48(7): 573-576.
[42]
Harsha M, Matthew B, Srinivas RP. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review[J]. BioMed Central, 2016, 14(1): 182-193.
[43]
Saad WE. Percutaneous management of postoperative anastomotic biliary strictures[J]. Tech Vasc Interv Radiol, 2008, 11(2): 143-153.
[44]
Halpenny DF, Torreggiani WC. The infectious complications of interventional radiology based procedures in gastroenterology and hepatology[J]. J Gastrointestin Liver Dis, 2011, 20(1): 71-75.
[45]
Saad WE, Wallace MJ, Wojak JC, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy[J]. J Vasc Interv Radiol, 2010, 21(6): 789-795.
[46]
Brody LA, Brown KT, Getrajdman GI, et al. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage[J]. J Vasc Interv Radiol, 1998, 9(4): 572-578.
[47]
Venkatesan AM, Locklin J, Dupuy DE, et al. Percutaneous ablation of adrenal tumors[J]. Tech Vasc Interv Radiol, 2010, 13(2): 89-99.
[48]
周建春, 赵孝杰, 彭启平, 等. 胆道手术患者胆汁培养及抗菌药物耐药性分析的临床研究[J]. 中华医院感染学杂志, 2011, 21(7): 1464-1467.
[49]
汪一帆, 艾芬. 胆道感染病原菌种类及药物敏感性分析[J].中国卫生检验杂志, 2012, 22(9): 2136-2138.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[6] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[7] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[8] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[9] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[12] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?